Back to Search
JOE RAMSDELL, M.D.
M.D.
Internal Medicine Physician
NPI: 1376569111Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
C34803(CA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Management of community-acquired pneumonia in the home: an American College of Chest Physicians clinical position statement.
PMID 15888856·Chest·2005
6-review
Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
PMID 12859222·Pharmacoeconomics·2003
8-other
DDT exposure of zebrafish embryos enhances seizure susceptibility: relationship to fetal p,p'-DDE burden and domoic acid exposure of California sea lions.
PMID 19165389·Environ Health Perspect·2009
7-preclinical
Modular psychotherapy for anxiety in older primary care patients.
PMID 19461257·Am J Geriatr Psychiatry·2009
2-rct
Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease.
PMID 19109202·J Immunol·2009
7-preclinical
Brevetoxin B is a clastogen in rats, but lacks mutagenic potential in the SP-98/100 Ames test.
PMID 19559041·Toxicon·2009
7-preclinical
Extraction of domoic acid from seawater and urine using a resin based on 2-(trifluoromethyl)acrylic acid.
PMID 18267137·Anal Chim Acta·2008
7-preclinical
Repeat exposure to ciguatoxin leads to enhanced and sustained thermoregulatory, pain threshold and motor activity responses in mice: relationship to blood ciguatoxin concentrations.
PMID 18280027·Toxicology·2008
7-preclinical
Semisynthesis of S-desoxybrevetoxin-B2 and brevetoxin-B2, and assessment of their acute toxicities.
PMID 18335998·Chem Res Toxicol·2008
7-preclinical
Liver genomic responses to ciguatoxin: evidence for activation of phase I and phase II detoxification pathways following an acute hypothermic response in mice.
PMID 18353800·Toxicol Sci·2008
4-observational
Ultrastructural damage to heart tissue from repeated oral exposure to yessotoxin resolves in 3 months.
PMID 18402996·Toxicon·2008
7-preclinical
Predicting worsening asthma control following the common cold.
PMID 18768579·Eur Respir J·2008
4-observational
Brevetoxin forms covalent DNA adducts in rat lung following intratracheal exposure.
PMID 18629316·Environ Health Perspect·2008
7-preclinical
Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients.
PMID 18094222·J Clin Pharmacol·2008
4-observational
In utero domoic acid toxicity: a fetal basis to adult disease in the California sea lion (Zalophus californianus).
PMID 18728728·Mar Drugs·2008
6-review
Intrinsic potency of synthetically prepared brevetoxin cysteine metabolites BTX-B2 and desoxyBTX-B2.
PMID 17689582·Toxicon·2007
7-preclinical
Transcriptional profiling of whole blood and serum protein analysis of mice exposed to the neurotoxin Pacific Ciguatoxin-1.
PMID 17868886·Neurotoxicology·2007
7-preclinical
Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema.
PMID 17983873·J Allergy Clin Immunol·2007
8-other
Embryonic exposure to domoic Acid increases the susceptibility of zebrafish larvae to the chemical convulsant pentylenetetrazole.
PMID 18007982·Environ Health Perspect·2007
7-preclinical
Maternal-fetal transfer of domoic acid in rats at two gestational time points.
PMID 18087593·Environ Health Perspect·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 W ARBOR DR
SAN DIEGO, CA 92103 - Phone
- (858) 657-8000
Quick Facts
- NPI
- 1376569111
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile